BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

153 related articles for article (PubMed ID: 6324374)

  • 41. Effects of expectorants on the canine tracheal ciliated cells.
    Yanaura S; Imamura N; Misawa M
    Jpn J Pharmacol; 1981 Dec; 31(6):957-65. PubMed ID: 7334738
    [TBL] [Abstract][Full Text] [Related]  

  • 42. [Mucociliary function and its alteration by certain irritants (author's transl)].
    Hée J; Guillerm R
    Bull Eur Physiopathol Respir; 1977; 13(1):11-25. PubMed ID: 14756
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Thiol-Based Drugs in Pulmonary Medicine: Much More than Mucolytics.
    Cazzola M; Calzetta L; Page C; Rogliani P; Matera MG
    Trends Pharmacol Sci; 2019 Jul; 40(7):452-463. PubMed ID: 31147200
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Effects of drugs on mucus glycoproteins and water in bronchial secretion.
    Medici TC; Radielovic P
    J Int Med Res; 1979; 7(5):434-42. PubMed ID: 40841
    [No Abstract]   [Full Text] [Related]  

  • 45. [Physiology and pathophysiology of bronchial secretion].
    Ficker JH
    Pneumologie; 2008 Mar; 62 Suppl 1():S11-3. PubMed ID: 18317975
    [TBL] [Abstract][Full Text] [Related]  

  • 46. [Clinical value of liquifying drugs of bronchial secretions].
    Molina C; Aiache JM; Pradelle J; Brun J; Cheminat JC
    Poumon Coeur; 1970; 26(1):91-102. PubMed ID: 4393035
    [No Abstract]   [Full Text] [Related]  

  • 47. [Bronchial mucolytic agents].
    Leuenberger P
    Rev Med Suisse Romande; 1996 May; 116(5):335-9. PubMed ID: 8693268
    [No Abstract]   [Full Text] [Related]  

  • 48. Evaluation of the activity of the carbocysteine-sobrerol combination on mucus spinnability.
    Distefano SM; Palermo F; Crimi N; Mistretta A; Pamparana F; Messa A
    Int J Clin Pharmacol Res; 1988; 8(1):31-5. PubMed ID: 3284830
    [TBL] [Abstract][Full Text] [Related]  

  • 49. [Modifications of the immunoglobulins in bronchial secretions induced by treatment with bromexin and oxytetracycline].
    Olivieri D; Bocchino M; Caputi M
    Arch Monaldi; 1970; 25(6):537-44. PubMed ID: 4105892
    [No Abstract]   [Full Text] [Related]  

  • 50. [Physicochemical characteristics of the tracheobronchial mucous secretion of lambs. Modification by a new mucolytic agent (Brovanexine UR-389)].
    Garcia-Rafanell J; Lleonart F
    Therapie; 1976; 31(4):483-90. PubMed ID: 12589
    [No Abstract]   [Full Text] [Related]  

  • 51. [Histochemical investigation on the mechanism of action of a synthetic mucolytic compound (Na 872 Cl): preliminary results].
    Pesce Delfino V; Ricco R
    Boll Soc Ital Biol Sper; 1979 Apr; 55(8):727-32. PubMed ID: 554641
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Effect of erdosteine and its metabolites on tracheobronchial mucus production and transport.
    Scuri R; Giannetti P; Paesano A
    Drugs Exp Clin Res; 1988; 14(11):693-8. PubMed ID: 3246214
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Effects of erdosteine and its metabolites on bacterial adhesiveness.
    Braga PC; Dal Sasso M; Sala MT; Gianelle V
    Arzneimittelforschung; 1999 Apr; 49(4):344-50. PubMed ID: 10337454
    [TBL] [Abstract][Full Text] [Related]  

  • 54. 2-(2,3-Dihydro-5-acetoxy-4,6,7-tribenzofuranyl)acetic acid (IRFI 016): a new antioxidant mucoactive drug.
    Scuri R; Giannetti P; Paesano A
    Drugs Exp Clin Res; 1990; 16(12):649-56. PubMed ID: 2130008
    [TBL] [Abstract][Full Text] [Related]  

  • 55. 50 years ago in the Journal of Pediatrics: the effect of N-acetylcysteine on the viscosity of tracheobronchial secretions in cystic fibrosis of the pancreas.
    Bear CE
    J Pediatr; 2013 Jan; 162(1):85. PubMed ID: 23260312
    [No Abstract]   [Full Text] [Related]  

  • 56. Nano-carrier systems: Strategies to overcome the mucus gel barrier.
    Dünnhaupt S; Kammona O; Waldner C; Kiparissides C; Bernkop-Schnürch A
    Eur J Pharm Biopharm; 2015 Oct; 96():447-53. PubMed ID: 25712487
    [TBL] [Abstract][Full Text] [Related]  

  • 57. [Problems in visiometry examining tracheo-bronchial-secretions (author's transl)].
    Heiden CL; Kornmesser HJ; Kretschmann A
    Laryngol Rhinol Otol (Stuttg); 1979 Mar; 58(3):264-8. PubMed ID: 439991
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Practical application of viscoelasticity measurements.
    Davis SS
    Eur J Respir Dis Suppl; 1980; 110():141-56. PubMed ID: 6938380
    [No Abstract]   [Full Text] [Related]  

  • 59. Effect of S-carboxymethylcysteine lysine salt on mucociliary clearance in rabbits with secretory cell metaplasia.
    Daffonchio L; De Santi MM; Gardi C; Lungarella G; Omini C
    Res Commun Mol Pathol Pharmacol; 1994 Oct; 86(1):59-74. PubMed ID: 7850257
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Pharmacokinetics of Sobrerol in chronic bronchitis. Comparison of serum and bronchial mucus levels.
    Braga PC; De Angelis L; Bossi R; Scaglione F; Scarpazza G; Allegra L; Fraschini F
    Eur J Clin Pharmacol; 1983; 24(2):209-15. PubMed ID: 6840169
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.